-
公开(公告)号:AU2010334915A1
公开(公告)日:2012-06-21
申请号:AU2010334915
申请日:2010-12-21
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: KLING ANDREAS , JANTOS KATJA , MACK HELMUT , MOLLER ACHIM , HORNBERGER WILFRIED , BACKFISCH GISELA , LAO YANBIN , NIJSEN MARJOLEEN
IPC: C07D207/28 , A61K31/4015 , A61K31/4439 , A61P9/00 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/28 , A61P27/08 , A61P31/00 , A61P31/18 , A61P35/00 , C07D401/04 , C07D401/14 , C07D417/14
Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R, R, R R, R, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R is optionally substituted phenyl-C-C-alkyl or hetaryl-C-C-alkyl, R is optionally substituted aryl, hetaryl, aryl-C-C-alkyl, aryl-C-C-alkenyl or hetaryl-C-C-alkyl, R is C-C-alkyl, C-C-haloalkyl, C-C-alkenyl, C-C-cycloalkyl, C-C-cycloalkyl-C-C-alkyl, or phenyl-C-C-alkyl, R and R independently of one another are halogen, CF, CHF, CHF, C-C-alkyl or C-C-alkoxy, and m and n independently of one another are 0 or 1.
-
公开(公告)号:CA2760464A1
公开(公告)日:2010-11-11
申请号:CA2760464
申请日:2010-05-06
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: MACK HELMUT , KLING ANDREAS , JANTOS KATJA , MOELLER ACHIM , HORNBERGER WILFRIED , HUTCHINS CHARLES W
IPC: C07D207/26 , A61K31/4412 , C07D211/76 , C07D233/34 , C07D239/10
Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula (Ia) and (Ib) in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2-CH2, CH2-CH2-CH2, N(Ry#)-CH2, N(Ry#)-CH2-CH2 or CH=CH-CH=, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.
-
公开(公告)号:BR112012015659A2
公开(公告)日:2016-05-24
申请号:BR112012015659
申请日:2010-12-21
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: MÖLLER ACHIM , KLING ANDREAS , BACKFISCH GISELA , MACK HELMUT , JANTOS KATJA , NIJSEN MARJOLEEN , HORNBERGER WILFRIED , LAO YANBIN
IPC: C07D401/04 , A61K31/4015 , A61K31/4439 , A61P9/00 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/28 , A61P27/08 , A61P31/00 , A61P31/18 , A61P35/00 , C07D207/28 , C07D401/14 , C07D417/14
Abstract: compostos de carboxamida e seu uso como inibidores de calpaína. a presente invenção refere-se a novos compostos de carboxamida e seu uso para a fabricação de um medicamento. os compostos de carboxamida são inibidores de calpaína (proteases de cisteína dependentes de cálcio). a invenção, portanto, também se refere á utilização destes compostos de carboxamida para o tratamento de um distúrbio associado a uma elevada atividade de calpaína. os compostos de carboxamida são compostoes da fórmula geral i em que r^ 1^, r^ 2^, r^ 3^, r^ 4^, r^ 5^, m e n tem os significados mencionados nas reivindicações e a descrição, os tautômeros do mesmos, os hidratos dos mesmos e os sais farmaceuticamente aceitáveis dos mesmos. destes compostos, são preferidos aqueles em que r^ 1^ é fenil-c~ 1~-c~ 2~-alquila ou hetaril-c~ 1~-c~ 2~alquila opcionalmente substituído, r^ 2^ é arila opcionalmente substituído, hetarila, aril-c~ 1~-c~ 6~-aqluila, aril-c~ 2~-c~ 6~-alquenila ou heraril-c~ 1~-c~ 4~-alquila, r^ 3^ é c~ 1~-c~ 3~-alquila, c~ 1~-c~ 3~-alquila, r^ 4^ e r^ 5^, independemente um do outro, são halogênio, cf~ 3~, chf~ 2~,ch~ 2~f, c~ 1~-c~ 2~-alquila ou c~ 1~-c~ 2-alcóxi, e m e n, independentemente um do outro, são 0 ou 1.
-
公开(公告)号:PH12013502359B1
公开(公告)日:2014-11-10
申请号:PH12013502359
申请日:2013-11-15
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: MACK HELMUT , KLING ANDREAS , JANTOS KATJA , MOELLER ACHIM , HORNBERGER WILFRIED , HUTCHINS CHARLES W
IPC: A61K31/4412 , C07D207/26 , C07D211/76 , C07D233/34 , C07D239/10
Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula (Ia) and (Ib) in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2-CH2, CH2-CH2-CH2, N(Ry#)-CH2, N(Ry#)-CH2-CH2 or CH=CH-CH=, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.
-
公开(公告)号:SG2014014740A
公开(公告)日:2014-07-30
申请号:SG2014014740
申请日:2010-05-06
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: MACK HELMUT , KLING ANDREAS , JANTOS KATJA , MOELLER ACHIM , HORNBERGER WILFRIED , HUTCHINS CHARLES W
-
公开(公告)号:NZ596000A
公开(公告)日:2013-10-25
申请号:NZ59600010
申请日:2010-05-06
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: MACK HELMUT , KLING ANDREAS , JANTOS KATJA , MOELLER ACHIM , HORNBERGER WILFRIED , HUTCHINS CHARLES W
IPC: C07D207/26 , A61K31/4412 , C07D211/76 , C07D233/34 , C07D239/10
Abstract: 596000 Disclosed herein are carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula (Ia) and (Ib) in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof.
-
公开(公告)号:CA2783714A1
公开(公告)日:2011-06-30
申请号:CA2783714
申请日:2010-12-21
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: KLING ANDREAS , JANTOS KATJA , MACK HELMUT , MOELLER ACHIM , HORNBERGER WILFRIED , BACKFISCH GISELA , LAO YANBIN , NIJSEN MARJOLEEN
IPC: C07D401/04 , A61K31/4439 , A61P25/00
Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R1, R2, R3 R4, R5,, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R1 is optionally substituted phenyl-C1-C2-alkyl or hetaryl-C1-C2-alkyl, R2 is optionally substituted aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl or hetaryl-C1-C4-alkyl, R3 is C3-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C2-alkyl, C3-C6- heterocycloalkyl-C1-C2-alkyl, phenyl-C1-C3-alkyl, pyridin-2-yl-C1-C3-alkyl or 1,3- benzoxazol-2-yl-methyl, R4 and R5 independently of one another are halogen, CF3, CHF2, CH2F, C1-C2-alkyl or C1-C2-alkoxy, and m and n independently of one another are 0 or 1.
-
公开(公告)号:CA2783704A1
公开(公告)日:2011-06-30
申请号:CA2783704
申请日:2010-12-21
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: KLING ANDREAS , JANTOS KATJA , MACK HELMUT , MOELLER ACHIM , HORNBERGER WILFRIED , BACKFISCH GISELA , LAO YANBIN , NIJSEN MARJOLEEN
IPC: C07D207/28 , A61K31/4015 , A61K31/4439 , A61P9/00 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/28 , A61P27/08 , A61P31/00 , A61P31/18 , A61P35/00 , C07D401/04 , C07D401/14 , C07D417/14
Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R1, R2, R3 R4, R5, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R1 is optionally substituted phenyl-C1-C2-alkyl or hetaryl-C1-C2-alkyl, R2 is optionally substituted aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl or hetaryl-C1-C4-alkyl, R3 is C1-C3-alkyl, C1-C3-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C2-alkyl, or phenyl-C1-C3-alkyl, R4 and R5 independently of one another are halogen, CF3, CHF2, CH2F, C1-C2-alkyl or C1-C2-alkoxy, and m and n independently of one another are 0 or 1.
-
公开(公告)号:CA2750993A1
公开(公告)日:2010-08-26
申请号:CA2750993
申请日:2010-02-19
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: KLING ANDREAS , MACK HELMUT , JANTOS KATJA , MOELLER ACHIM , HORNBERGER WILFRIED , HUTCHINS CHARLES W
IPC: C07D277/22 , A61K31/4439 , A61P25/00 , A61P31/18 , A61P35/00 , C07D401/04 , C07D413/04 , C07D417/04
Abstract: The present invention relates to novel carboxamide compounds and their use as a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity and to a method for the therapeutic and/or prophylactic treatment by administering an effective amount of at least one of these carboxamide compounds. The carboxamide compounds are compounds of the general formula (I) in which W-R2 is selected from formulae (1), (2) and (3) and R1, R2, R3a, R3b, Y1, Y2, Y3, Y4, X, Q, m, k, Rw and Rw* have the meanings mentioned in the claims, the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y1, Y2, Y3 and Y4 are CRy, or one or two of the variables Y1 to Y4 are a nitrogen atom and the remaining variables are CRy, wherein the radicals Ry may be identical or different and have the meanings mentionend in the claims.
-
公开(公告)号:SG181915A1
公开(公告)日:2012-07-30
申请号:SG2012046850
申请日:2010-12-21
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: KLING ANDREAS , JANTOS KATJA , MACK HELMUT , MOELLER ACHIM , HORNBERGER WILFRIED , BACKFISCH GISELA , LAO YANBIN , NIJSEN MARJOLEEN
Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R1, R2, R3 R4, R5, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R1 is optionally substituted phenyl-C1-C2-alkyl or hetaryl-C1-C2-alkyl, R2 is optionally substituted aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl or hetaryl-C1-C4-alkyl, R3 is C1-C3-alkyl, C1-C3-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C2-alkyl, or phenyl-C1-C3-alkyl, R4 and R5 independently of one another are halogen, CF3, CHF2, CH2F, C1-C2-alkyl or C1-C2-alkoxy, and m and n independently of one another are 0 or 1.
-
-
-
-
-
-
-
-
-